Literature DB >> 7016989

Infection with influenza A/Victoria virus in Houston families, 1976.

L H Taber, A Paredes, W P Glezen, R B Couch.   

Abstract

In 1976, an epidemic caused by infections with an influenza virus antigenically similar to A/Victoria/75 (H3N2) occurred in Houston, Texas. During this outbreak, 37 families (155 members) enrolled in the Houston Family Study were under observation. The families lived throughout the metropolitan area (Houston, Texas), and were representative of low income groups. The overall frequency of infection in family members was 27.7%. The frequency of infection was the highest for infants under one year of age and for their older siblings, 14 (37.8%) of 37 and 17 (33.3%) of 51, respectively. Eighteen (48.6%) of the 37 families had at least one infected member. Twelve of the 18 'infected' families had school aged children, whereas only three of the 19 'non-infected' families had school aged children (P less than 0.01). These infected families were also larger and had increased household density (persons/rooms). The levels of pre-existing HI antibodies to A/Victoria/75 and A/Port Chalmers/73 were inversely related to frequencies of infection and illness associated with A/Victoria/75 virus. Three children required hospitalization as direct consequence of their infection with this H3N2 influenza virus. Antibody response to infection was related to previous experience with antigenically-related influenza A (H3N2) viruses according to Francis', 'doctrine of original antigenic sin.'

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016989      PMCID: PMC2133985          DOI: 10.1017/s0022172400069059

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  17 in total

1.  Epidemiologic studies on influenza in familial and general population groups, 1951-1956. II. Characteristics of occurrence.

Authors:  R N PHILIP; J A BELL; D J DAVIS; M O BEEM; P M BEIGELMAN; J I ENGLER; G W MELLIN; J H JOHNSON; A M LERNER
Journal:  Am J Hyg       Date:  1961-03

2.  Epidemiologic studies of Asian influenza in a Louisiana parish.

Authors:  F L DUNN; D E CAREY; A COHEN; J D MARTIN
Journal:  Am J Hyg       Date:  1959-11

3.  The current status of the control of influenza.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1955-09       Impact factor: 25.391

4.  Clinically useful method for the isolation of respiratory syncytial virus.

Authors:  C B Hall; R G Douglas
Journal:  J Infect Dis       Date:  1975-01       Impact factor: 5.226

5.  Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic.

Authors:  G MEIKLEJOHN; C H KEMPE; W G THALMAN; E H LENNETTE
Journal:  Am J Hyg       Date:  1952-01

6.  An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness.

Authors:  S B Greenberg; R B Couch; J A Kasel
Journal:  Am J Epidemiol       Date:  1974-09       Impact factor: 4.897

7.  A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.

Authors:  A Sugiura; H Yanagawa; C Enomoto; M Ueda; K Tobita
Journal:  J Infect Dis       Date:  1970-12       Impact factor: 5.226

8.  Interpandemic influenza in the Houston area, 1974-76.

Authors:  W P Glezen; R B Couch
Journal:  N Engl J Med       Date:  1978-03-16       Impact factor: 91.245

9.  Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans.

Authors:  B D Baxter; R B Couch; S B Greenberg; J A Kasel
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

10.  Influenza in children. Relationship to other respiratory agents.

Authors:  W P Glezen; A Paredes; L H Taber
Journal:  JAMA       Date:  1980-04-04       Impact factor: 56.272

View more
  22 in total

1.  Effect of school closure on the incidence of influenza among school-age children in Arizona.

Authors:  Colleen C Wheeler; Laura M Erhart; Megan L Jehn
Journal:  Public Health Rep       Date:  2010 Nov-Dec       Impact factor: 2.792

2.  Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum.

Authors:  Alison P Galvani; Timothy C Reluga; Gretchen B Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

Review 3.  Influenza. The role of burden-of-illness research.

Authors:  T D Szucs
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

4.  Prioritization of delayed vaccination for pandemic influenza.

Authors:  Eunha Shim
Journal:  Math Biosci Eng       Date:  2011-01       Impact factor: 2.080

5.  The shifting demographic landscape of influenza.

Authors:  Shweta Bansal; Babak Pourbohloul; Nathaniel Hupert; Bryan Grenfell; Lauren Ancel Meyers
Journal:  PLoS Curr       Date:  2009-10-01

6.  Effects of social and family factors on viral respiratory infection and illness in the first year of life.

Authors:  G Gardner; A L Frank; L H Taber
Journal:  J Epidemiol Community Health       Date:  1984-03       Impact factor: 3.710

7.  The shifting demographic landscape of pandemic influenza.

Authors:  Shweta Bansal; Babak Pourbohloul; Nathaniel Hupert; Bryan Grenfell; Lauren Ancel Meyers
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

8.  Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.

Authors:  J A Kasel; A L Frank; W A Keitel; L H Taber; W P Glezen
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

9.  Optimizing allocation for a delayed influenza vaccination campaign.

Authors:  Jan Medlock; Lauren Ancel Meyers; Alison Galvani
Journal:  PLoS Curr       Date:  2009-12-09

10.  Influenza excess mortality from 1950-2000 in tropical Singapore.

Authors:  Vernon J Lee; Jonathan Yap; Jimmy B S Ong; Kwai-Peng Chan; Raymond T P Lin; Siew Pang Chan; Kee Tai Goh; Yee-Sin Leo; Mark I-Cheng Chen
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.